Companies/VitaSpring Biomedical Co. Ltd.

Company profile

VitaSpring Biomedical Co. Ltd.

OTC: VSBC · Healthcare · Biotechnology

PublicHQ Irvine, CA · OrangeCIK 0001697884Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

18D

FH 14DQ 24GM —SS 23

v0.1 · 55/100 weight · provisional

↑ Piotroski F, disclosure history · ↓ workforce scale, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$415.4k

Employees

Market cap

$2.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02026

Net income-$415.4k-$415.4k2026

Operating income-$385.4k-$385.4k2026

Total assets$14.7k$14.7k2026

Liabilities$4.4M$4.4M2026

Equity-$4.4M-$4.4M2026

Revenue trend

FY2019 – FY2026 · USD

$17.2k

FY19

$15.1k

FY21

$248.2k

FY21

$5.6M

FY21

FY23

FY24

FY25

FY26

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

VitaSpring Biomedical Co. Ltd. booked $0 in FY2026 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Telo Genomics Corp.——PMGC Holdings Inc.28D Bio Green Med Solution, Inc.47D Digital Commodities Inc.52D

Neighbors

Orange →

Edwards Lifesciences Corporation$6.1B86A Chipotle Mexican Grill, Inc.$11.9B76B+Rivian Automotive, Inc.$5.4B37D TTM Technologies, Inc.$2.9B73B American Healthcare REIT, Inc.$2.1B54D CareTrust REIT, Inc.$1.2M68B

Key facts

CEOSsu-Chuan Lai

SectorHealthcare

IndustryBiotechnology

HeadquartersIrvine, CA

ExchangeOTC: VSBC

Employees1

IPO date2019-11-13

Latest filings

10-Q2026-06-17 10-Q2026-06-17 10-K2026-06-17 10-Q2026-06-17 10-Q2026-06-15 10-K2026-06-08 10-Q2026-05-06 10-Q2026-04-22

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.